Hepatic tumors with hyperglucagonemia response to treatment with human lymphoblastoid interferon

Cancer

Volumn 62, Issue 5, 1988, Pages 912-914

  Sheehan‐Dare, Robert A ^a   Simmons, Adrian V ^a   Cotterill, John A ^b   Janke, Phillip G ^c  

^a St James University   (United Kingdom)

^b General Infirmary ^*  (United Kingdom)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON;

AGE; CASE REPORT; HUMAN; HYPERGLUCAGONEMIA; LIVER TUMOR; MALE; NEUTROPENIA; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADENOMA, ISLET CELL; CASE REPORT; ERYTHEMA; GLUCAGONOMA; HUMAN; INTERFERON TYPE I; LIVER NEOPLASMS; MALE; MIDDLE AGE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0023742675     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19880901)62:5<912::AID-CNCR2820620510>3.0.CO;2-0     Document Type: Article

References (11)

1. Clinical and metabolic aspects of Glucagonoma
2. Elevated plasma pro‐glucagon like component with a glucagon secreting tumour. Effect of streptozotocin
3. Effects of leucocyte interferon on symptoms and hormone levels in patients with mid gut carcinoid tumours and carcinoid syndrome
4. Successful treatment of therapy resistant pancreatic cholera with human leucocyte interferon
5. Molecular forms of human enteroglucagon in tissue and plasma: Plasma responses to nutrient stimuli in health and disorders of the upper gastrointestinal tract
6. Molecular forms of glucagon like immunoreactivity in porcine intestine and pancreas
7. Rapid improvement of skin lesions in glucagonomas with intravenous somatostatin infusion
8. Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 20–995)
9. Treatment of patients with pancreatic endocrine tumours using a new long‐active somatostatin analogue symptoatic and peptide responses
10. Treatment of the malignant carcinoid syndrome. Evaluation of a long‐acting somatostatin analogue
11. Long term treatment of a vipoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases